Shockwave Therapy for Erectile Dysfunction, Two Years On

Most treatments for erectile dysfunction ask you to plan around a pill. A long-running trial from the University of Virginia tested something different: shockwave therapy for erectile dysfunction, a few weeks of low-intensity pulses aimed at improving blood flow, then nothing. The results, newly reported this week, suggest the effect holds for up to two years before fading.

The trial is one of the few to follow patients this long. Earlier work had shown short-term improvement at six months or less, but almost nobody had checked whether shockwave therapy for erectile dysfunction keeps working years later. That gap is what the Virginia team set out to close.

What the Virginia trial actually tested

Thirty men with erectile dysfunction were randomized to receive either shockwave therapy for erectile dysfunction or a sham treatment, with the placebo group crossing over to the real thing after one month, according to the Educated Patient's report on the study. The protocol ran twice a week for three consecutive weeks, delivering three thousand low-intensity shockwaves per session to the base and shaft of the penis and the surrounding tissue. David K. Charles, M.D., a urologist affiliated with the Department of Urology at the University of Virginia, was among the investigators, the Educated Patient reported.

The men were not a young or uncomplicated group. The median participant was sixty-nine years old, one in five had a history of diabetes, seventeen percent had low testosterone at baseline, and nearly a quarter had smoked. At the start, their average score on the Sexual Health Inventory for Men was ten point eight, which the researchers classified as moderate erectile dysfunction.

Patients returned for follow-up visits at roughly one, two, and three years after treatment. Erectile function was measured with two standard scales, the Sexual Health Inventory for Men and the Erection Hardness Score, and patients also rated their satisfaction with the treatment.

The gains peak at one year, then fade

The pattern for shockwave therapy for erectile dysfunction was consistent across both measures. By the one-year mark, the average inventory score had climbed to fifteen point six, and it was still fifteen point zero at two years, both statistically significant improvements over baseline. The hardness scores told the same story, rising from one point eight seven to two point seven at one year and holding at two point six six at two years. By year three, both measures had slid back, to twelve point two on the inventory and two point two nine on hardness, no longer statistically different from where the men started.

Patient satisfaction landed in the moderate range, and the study recorded no adverse events, the Educated Patient reported. It is the first long-term evidence that shockwave therapy for erectile dysfunction holds up well beyond the six-month window most earlier research covered. The investigators concluded that the findings support the therapy as a safe option, while writing that "further research is needed to standardize treatment protocols, as well as to explore the potential opportunity for multiple treatment courses in patients who do not have a sustained improvement in erectile function."

The trial of shockwave therapy for erectile dysfunction had real limits. Thirty patients is a small sample, all of them were treated at a single institution, and everyone was unblinded after the crossover, which makes it hard to separate true treatment effects from placebo response during the long follow-up. The investigators flagged that issue themselves, noting that erectile dysfunction treatments commonly show a strong placebo response.

Why this matters even if you are not sixty-nine

The trial participants skew older, but erectile dysfunction is not an old-man-only problem anymore. A separate study published in the International Journal of Clinical Practice this year found a dose-response relationship between workplace psychological stress and erectile function in eight hundred twenty-six full-time working men between the ages of twenty-two and forty, according to Medical Xpress. Men in the high-stress group faced ten times the odds of erectile dysfunction compared with the low-stress group.

That context helps explain the appeal of shockwave therapy for erectile dysfunction among men who would rather not plan intimacy around a tablet. Pills work by temporarily changing blood flow, and other options tend to be more invasive, which is part of why they never caught on widely. A noninvasive option that keeps working for two years without a daily or on-demand routine is a different proposition, even if the evidence is still early and the sample is small.

One thing the data does not support: calling shockwave therapy for erectile dysfunction a permanent fix, at least not from a single course. The three-year data suggests the body eventually reverts, which is why the researchers are interested in whether repeat courses could extend the benefit. Anyone considering it should talk to a urologist about whether they are a candidate, and keep expectations tied to what the data actually shows: roughly two good years, peaking around month twelve.

For now, the takeaway is modest but real. A treatment that takes three weeks and gives back up to two years of improved function, with no side effects reported in this trial, belongs in the conversation alongside the options most men already know about, like the inflammation angle researchers recently explored in erectile dysfunction drugs and the depression medication that unexpectedly improved sexual function. The science of the bedroom is finally getting the long-term follow-up it should have had all along.